Lifco Ab (LIFCO.B) AI Stock Analysis

• Market Cap: kr132.36B
• Dividend Yield: 0.69%
• Average Volume (3M): 296.63K
• Price to Earnings (P/E): 38.6
• Beta (1Y): 1.08
• Revenue Growth: 9.39%
• EPS Growth: 10.45%
• Country: SE
• Employees: 7,424
• Sector: General
• Sector Strength: N/A
• Industry: Conglomerates
• EPS (TTM): 2.28
• Shares Outstanding: 423,836,460
• 10 Day Avg. Volume: 318,820
• 30 Day Avg. Volume: 296,626
• PEG Ratio: 4.38
• Price to Book (P/B): 8.35
• Price to Sales (P/S): 5.66
• P/FCF Ratio: 34.36
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: kr340.00
• Price Target Upside: 1.07% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 1
• EPS Forecast (FY): 9.73
• Revenue Forecast (FY): kr29.87B

• Rating: 62 Neutral
• Price Target: kr325.00 ▼(-3.39% Downside)
• Action: Reiterated Date: 02/01/26
• Date: Action: Reiterated 02/01/26

The score is supported primarily by strong fundamentals, including solid profitability and reliable free cash flow. It is held back by weak technicals (downtrend and negative momentum) and a stretched valuation (high P/E with a low dividend yield).

Positive Factors

Revenue Growth

Sustained multi-year revenue expansion across the group's segments strengthens scale and resilience. Durable top-line growth supports ongoing investment in product development, distribution and service capabilities, enabling structural margin leverage and funding for strategic initiatives.

Free Cash Flow Quality

FCF closely tracking earnings indicates high earnings quality and dependable internal funding. Strong, repeatable cash generation supports capital expenditure, de-leveraging, acquisitions or shareholder returns without reliance on external finance, improving long-term financial flexibility.

Balance Sheet Resilience

Moderate and improving leverage combined with a materially larger equity base reduces refinancing and solvency risk. A stronger capital structure increases capacity for bolt-on M&A, cyclical shocks and strategic investment while preserving optionality for long-term growth.

Negative Factors

Declining Return on Equity

A downward ROE trend signals waning capital efficiency, which can persistently compress shareholder returns if not addressed. Structural drivers could include tougher competition, pricing pressure or capital dilution, limiting the firm's ability to sustain high return profiles over time.

Free Cash Flow Volatility

Intermittent FCF growth undermines predictability of funding for capex, dividends and M&A. Even with high absolute FCF, variability forces conservative capital allocation, can delay strategic projects, and increases the need for liquidity buffers during weaker periods.

Margin Pressure

A deterioration in operating and net margins, even if modest, can erode profitability over time if persistent. Structural mix shifts or rising input costs that aren't offset by pricing or efficiency gains will pressure cash flow conversion and reduce headroom for reinvestment.

Lifco Ab Business Overview & Revenue Model

Company Description

Lifco AB (publ) engages in the dental, demolition and tools, and systems solutions businesses in Sweden, Norway, Germany, rest of Europe, Asia, Australia, North America, and internationally. It is involved in the distribution of dental equipment, such as disinfectants, saliva ejectors, bite registration and dental impression materials, bonding agents, and other consumables, as well as develops and sells medical record systems. The company also operates dental laboratory. In addition, it develops, manufactures, and sells demolition robots, and crane and excavator attachments to construction and earthworks, snow clearing, demolition, pipe and cable laying, forestry work, scrap handling and railway works. Further, the company engages in the contract manufacturing of electronic components, stainless steel products, and galvanized products for use in the security and alarm, industrial applications, telecom and IT, food products, and pharmaceutical industries; and the waste handling and recycling of tires, wires, refrigerators, aluminum products, and electronics. Additionally, it offers vehicle racking systems for service vans; equipment for sawing and handling of sawn lumber, as well as pellet mills; cleaning and sealing of pipes, as well as electrical supplies, and LED-lighting and measuring instruments for the surveying and construction industries; and telecom equipment to fiber market and aluminum cabinets. The company was founded in 1946 and is based in Enköping, Sweden. Lifco AB (publ) is a subsidiary of Carl Bennet AB.

How the Company Makes Money

Lifco AB generates revenue through multiple streams, primarily from the sale of its products in the aforementioned sectors. The Dental segment earns income through the sale of dental equipment, instruments, and consumables to dental practices and clinics, while the Demolition & Tools segment derives revenue from providing specialized tools and equipment for construction and demolition activities. Additionally, the Systems solutions segment contributes to earnings by offering customized solutions and support services to various industrial clients. The company also benefits from strategic partnerships with suppliers and distributors, enhancing its market reach and product offerings, which further supports its revenue generation efforts.

Lifco Ab Financial Statement Overview

Summary

Strong multi-year revenue growth with consistently healthy margins and high-quality cash generation (free cash flow closely tracks earnings). Balance sheet leverage is moderate and improving, though returns on equity have softened versus earlier highs and cash flow growth has shown some variability.

Income Statement

Revenue has grown strongly over the period, rising from 17.5bn (2021) to 28.3bn (2025), with 2025 showing an unusually high growth print versus prior years. Profitability is consistently solid: gross margin has stayed around the low-to-mid 40% range and operating profitability remains healthy (operating margin ~18–20% most years). Net margin is stable around ~12–14%, though it dipped versus 2023, and 2025 margins were slightly softer than 2024—suggesting modest mix/cost pressure despite continued earnings growth.

Balance Sheet

The company shows a sound capital structure with moderate leverage: debt relative to equity sits around ~0.57–0.65 and has improved from the higher levels seen in 2021–2023. Equity has expanded meaningfully (from 10.6bn in 2021 to 19.1bn in 2025) alongside asset growth, supporting balance sheet resilience. Returns on equity are attractive (~18–22%), but have trended down from the 2021–2023 highs, which slightly offsets the otherwise steady balance sheet profile.

Cash Flow

Cash generation is a key strength: free cash flow is consistently high and closely tracks reported earnings (free cash flow is ~88–91% of net income across years), indicating good earnings quality. Operating cash flow has scaled up over time (2.9bn in 2021 to 5.1bn in 2025) and free cash flow reached 4.7bn in 2025. The main weakness is volatility in free cash flow growth (notably flat-to-down in 2024 after a strong 2023), even though the overall level remains robust.

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	28.25B	26.14B	24.45B	21.55B	17.48B
Gross Profit	12.34B	11.59B	10.82B	9.01B	7.33B
EBITDA	7.03B	6.66B	5.08B	5.13B	4.08B
Net Income	3.63B	3.30B	3.27B	2.78B	2.39B
Balance Sheet
Total Assets	41.11B	38.89B	34.29B	29.77B	24.88B
Cash, Cash Equivalents and Short-Term Investments	1.88B	1.52B	1.59B	1.70B	1.51B
Total Debt	10.99B	10.36B	9.52B	8.26B	6.91B
Total Liabilities	21.83B	20.48B	18.96B	16.43B	14.12B
Stockholders Equity	19.14B	18.26B	15.21B	13.24B	10.64B
Cash Flow
Free Cash Flow	4.65B	3.95B	4.02B	2.72B	2.63B
Operating Cash Flow	5.12B	4.49B	4.46B	3.07B	2.94B
Investing Cash Flow	-3.83B	-3.34B	-4.16B	-2.72B	-3.29B
Financing Cash Flow	-788.00M	-1.40B	-346.00M	-308.00M	573.00M

Lifco Ab Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 336.40
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:LIFCO.B, the sentiment is Negative. The current price of 336.4 is above the 20-day moving average (MA) of 308.67, above the 50-day MA of 317.34, and below the 200-day MA of 344.50, indicating a bearish trend. The MACD of -6.94 indicates Positive momentum. The RSI at 33.19 is Neutral, neither overbought nor oversold. The STOCH value of 20.57 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:LIFCO.B.

Lifco Ab Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
LOOMIS	71 Outperform	kr27.81B	16.76	12.76%	3.63%	2.58%	19.07%
SECU.B	69 Neutral	kr90.09B	12.34	13.15%	3.10%	-0.74%	6.55%
LIFCO.B	62 Neutral	kr132.36B	38.60	19.96%	0.69%	9.39%	10.45%
NOLA.B	58 Neutral	kr13.32B	21.43	14.22%	2.48%	0.40%	38.42%
Sector *	55 Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
VOLO	55 Neutral	kr6.31B	28.13	14.16%	1.91%	9.65%	19.40%
BERG.B	45 Neutral	kr7.56B	37.27	-3.67%	1.25%	4.65%	-136.09%

Lifco Ab Corporate Events

Lifco Expands Dental Portfolio with Acquisition of UK-Based Ethoss Regeneration

Lifco AB has agreed to acquire a majority stake in UK-based Ethoss Regeneration Ltd, a specialist in regenerative bone graft materials used in dentistry and oral surgery and sold globally. Ethoss, which generated about GBP 5.4 million in net sales in the year to July 2025 and employs 16 people in Silsden, England, will be integrated into Lifco’s Dental business area from the first quarter of 2026, with the transaction expected to have no significant impact on Lifco’s earnings or financial position for the current year, but to further strengthen its dental portfolio and niche positioning in advanced dental materials.

The most recent analyst rating on ($SE:LIFCO.B) stock is a Hold with a SEK326.00 price target. To see the full list of analyst forecasts on Lifco Ab stock, see the SE:LIFCO.B Stock Forecast page.

Lifco Delivers Higher 2025 Earnings and Cash Flow While Accelerating Acquisition Strategy

Lifco AB reported another year of earnings growth in 2025, with net sales up 8.1% to SEK 28.3 billion and EBITA rising 6.8% to SEK 6.3 billion, driven by both organic expansion and acquisitions despite negative currency effects. The EBITA margin remained robust at 22.4%, net profit increased 9.6%, cash flow from operating activities grew 10.7%, and the board proposed a higher dividend of SEK 2.70 per share, underscoring strong cash generation and shareholder returns. The group consolidated 16 new niche, market-leading businesses—six in Dental and ten in Systems Solutions—across several European countries, and with net debt at just 1.1 times EBITDA and ample MTN capacity, Lifco signalled significant headroom for further acquisitions to reinforce its buy-and-build strategy.

The most recent analyst rating on ($SE:LIFCO.B) stock is a Hold with a SEK326.00 price target. To see the full list of analyst forecasts on Lifco Ab stock, see the SE:LIFCO.B Stock Forecast page.

Lifco Sets Date for Fourth-Quarter and Year-End 2025 Results

Lifco AB will publish its fourth-quarter and full-year 2025 results on 30 January at 7:30 a.m. CET, followed by a webcast and teleconference presentation at 9:00 a.m. CET with CEO Per Waldemarson and CFO Therése Hoffman. The scheduled report and investor presentation underscore Lifco’s ongoing communication with the capital market and provide an opportunity for analysts and investors to assess the performance and strategic progress of its diversified portfolio of niche businesses across dental, demolition & tools, and systems solutions segments.

The most recent analyst rating on ($SE:LIFCO.B) stock is a Hold with a SEK370.00 price target. To see the full list of analyst forecasts on Lifco Ab stock, see the SE:LIFCO.B Stock Forecast page.

Lifco Expands Dental Portfolio with Acquisition of German Microscope Maker Karl Kaps

Lifco AB has agreed to acquire all shares in Karl Kaps GmbH & Co. KG, a German niche manufacturer of medical and dental microscopes based in Asslar with 33 employees and 2024 net sales of about EUR 10.1 million. Karl Kaps will be integrated into Lifco’s Dental business area, with consolidation planned for the first quarter of 2026, and the deal is not expected to have a significant impact on Lifco’s earnings or financial position for the 2026 financial year, underscoring Lifco’s strategy of adding specialised, market‑leading companies to strengthen its dental portfolio without materially altering its overall financial profile.

The most recent analyst rating on ($SE:LIFCO.B) stock is a Hold with a SEK370.00 price target. To see the full list of analyst forecasts on Lifco Ab stock, see the SE:LIFCO.B Stock Forecast page.

Lifco AB Acquires UK-Based DB Orthodontics

Lifco AB has acquired DB Orthodontics Ltd, a UK-based company that produces and sells orthodontic materials to dental professionals globally. The acquisition, which will be consolidated into Lifco’s Dental business area in the fourth quarter of 2025, is not expected to significantly impact Lifco’s earnings or financial position this year.

The most recent analyst rating on ($SE:LIFCO.B) stock is a Hold with a SEK356.00 price target. To see the full list of analyst forecasts on Lifco Ab stock, see the SE:LIFCO.B Stock Forecast page.

Lifco AB Proposes New Board Member Anders Oscarsson

Lifco AB’s Nomination Committee has proposed Anders Oscarsson for the Board of Directors, replacing Axel Wachtmeister, who will not seek re-election in 2026. Oscarsson’s extensive experience in equities and owner relations at AMF is expected to bring valuable insights to Lifco’s strategic direction, potentially impacting its operations and stakeholder relations positively.

The most recent analyst rating on ($SE:LIFCO.B) stock is a Hold with a SEK356.00 price target. To see the full list of analyst forecasts on Lifco Ab stock, see the SE:LIFCO.B Stock Forecast page.

Lifco AB Expands with Acquisition of HEGUtechnik GmbH

Lifco AB has acquired a majority stake in HEGUtechnik GmbH, a German niche contract manufacturer specializing in electronic components for automation in harsh industrial environments. This acquisition, which will be consolidated into Lifco’s Business Area Systems Solutions, is not expected to significantly impact Lifco’s financials this year but strengthens its position in the contract manufacturing sector.

The most recent analyst rating on ($SE:LIFCO.B) stock is a Hold with a SEK390.00 price target. To see the full list of analyst forecasts on Lifco Ab stock, see the SE:LIFCO.B Stock Forecast page.